Technical Analysis for GBT - Global Blood Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 62.33 6.11% 3.59
GBT closed up 6.11 percent on Wednesday, April 8, 2020, on 1.18 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical GBT trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Multiple of Ten Bullish Other 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
Medicine Biopharmaceutical Medical Specialties Blood Sickle Cell Disease Hereditary Angioedema Angioedema Hemoglobin Hemoglobins

Is GBT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 87.54
52 Week Low 39.95
Average Volume 911,295
200-Day Moving Average 59.18
50-Day Moving Average 60.82
20-Day Moving Average 50.45
10-Day Moving Average 53.67
Average True Range 5.08
ADX 25.28
+DI 26.47
-DI 15.89
Chandelier Exit (Long, 3 ATRs ) 48.63
Chandelier Exit (Short, 3 ATRs ) 55.18
Upper Bollinger Band 60.43
Lower Bollinger Band 40.48
Percent B (%b) 1.1
BandWidth 39.55
MACD Line -0.86
MACD Signal Line -2.96
MACD Histogram 2.0981
Fundamentals Value
Market Cap 2.72 Billion
Num Shares 43.7 Million
EPS -2.46
Price-to-Earnings (P/E) Ratio -25.34
Price-to-Sales 0.00
Price-to-Book 5.19
PEG Ratio -0.38
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 71.14
Resistance 3 (R3) 70.39 66.71 69.67
Resistance 2 (R2) 66.71 64.46 67.08 69.18
Resistance 1 (R1) 64.52 63.08 65.61 65.27 68.69
Pivot Point 60.83 60.83 61.38 61.21 60.83
Support 1 (S1) 58.64 58.59 59.74 59.39 55.97
Support 2 (S2) 54.96 57.20 55.33 55.48
Support 3 (S3) 52.77 54.96 54.99
Support 4 (S4) 53.52